RR:NASDAQRichtech Robotics Inc. Analysis
Data as of 2026-09-06 - not real-time
$1.75
Latest Price
9/10Risk
Risk Level: High
Executive Summary
Richtech Robotics Inc. trades at $1.75, with its moving averages tangled rather than clearly stacked — a neutral trend structure. It has gained 12.9% over the past 30 days. Momentum indicators put RSI at 49.8 (neutral) with MACD reading bullish. Price has been bracketed by support at $1.55 and resistance at $1.99.
On valuation the read is undervalued — earnings multiple of 25.0 versus a 28.5 sector average, below the peer group. Analyst price targets sit 14.3% above the current price. Revenue is growing at 16.7% on a -81.8% profit margin.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 96.5%, a beta of 3.99 and a maximum drawdown of 80.9%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 1 out of 10.
On valuation the read is undervalued — earnings multiple of 25.0 versus a 28.5 sector average, below the peer group. Analyst price targets sit 14.3% above the current price. Revenue is growing at 16.7% on a -81.8% profit margin.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 96.5%, a beta of 3.99 and a maximum drawdown of 80.9%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 1 out of 10.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 1/10
Key Factors
- Trading below the 200-day average of 2.63
- MACD momentum is positive
- 30-day price change of +12.9%
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- P/E of 25.0 versus sector average of 28.5
- Trading below the 200-day average of 2.63
- Analyst targets imply +14.3% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 1/10
Key Factors
- P/E of 25.0 versus sector average of 28.5
- Negative profit margin of -81.8%
- Analyst targets imply +14.3% versus the current price
Key Metrics & Analysis
Financial Health
Revenue Growth16.70%
Profit Margin-81.78%
P/E Ratio25.0
ROE-1.87%
ROA-7.37%
Debt/Equity0.17
P/B Ratio1.1
Op. Cash Flow$-7202000
Free Cash Flow$-27231376
Industry P/E28.5
Technical Analysis
TrendNeutral
RSI49.8
Support$1.55
Resistance$1.99
MA 20$1.76
MA 50$1.72
MA 200$2.63
MACDBullish
VolumeIncreasing
Fear & Greed Index95.48
Valuation
Target Price$2.00
Upside/Downside14.29%
GradeUndervalued
TypeBlend
Risk Assessment
Beta3.99
Volatility96.50%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.